Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPMC as Add-on to Rescue Treatment in Allergic Rhinitis
NCT02557269Phase 4Unknown
- Sponsor
- American Lung Association
- Start
- May 2015
- Primary completion
- Oct 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hypromellose in seasonal allergic rhinitis (SAR), sponsored by American Lung Association. Status: unknown.
02
Drugs
hypromellose
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02557269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557269.